ARTICLE | Clinical News
Epizyme, Eisai preclinical data
March 3, 2014 8:00 AM UTC
In a mouse xenograft model of enhancer of zeste homolog 2 (EZH2)-mutant bearing NHL, EPZ-6438 led to dose-dependent tumor growth inhibition, including complete and sustained regressions. Additionally...